Anti-Human APP Abeta Recombinant Antibody(Bapineuzumab)
-
产品编号
YR1164
-
别名
科研级 Bapineuzumab ( 巴匹组单抗 ), Anti-APP Abeta Recombinant Antibody, Research Grade Bapineuzumab
-
规格
- 1mg
- 5mg
Alias | 科研级 Bapineuzumab ( 巴匹组单抗 ), Anti-APP Abeta Recombinant Antibody, Research Grade Bapineuzumab |
Catalog Number | YR1164 |
Molecular Name | Bapineuzumab |
CAS Number | 648895-38-9 |
Target | APP Abeta[Homo sapiens] |
Antibody Isotype | IgG1 |
Clonity | Monoclonal |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Formulation | PBS, pH7.5 |
Shipping Condition | Shipped on ice packs. |
Background | Bapineuzumab (nicknamed "bapi") is a humanized monoclonal antibody that acts on the nervous system and may have potential therapeutic value for the treatment of Alzheimer's disease and possibly glaucoma. However, in 2012 it failed to produce significant cognitive improvements in patients in two major trials, despite lowering key biomarkers of AD, amyloid brain plaque and hyperphosphorylated tau protein in CSF. |
Host | Mouse |
Application | WB, FuncS, IF, Neut, ELISA, FCM, IP |
Remarks | This product is for research use only. |